| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of ADIPOQ mRNA | CTD | PMID:17557909 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1351472 | 6480464 | Ethinyl Estradiol results in decreased expression of ADIPOQ mRNA | CTD | PMID:18936297 |
| 17beta-estradiol | decreases expression | ISO | RGD:1552054 | 6480464 | Estradiol results in decreased expression of ADIPOQ mRNA | CTD | PMID:16643890 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of ADIPOQ mRNA | CTD | PMID:17010207 |
| 2,2',5,5'-tetrachlorobiphenyl | affects expression | ISO | RGD:1351472 | 6480464 | 2,5,2',5'-tetrachlorobiphenyl affects the expression of ADIPOQ mRNA | CTD | PMID:21703328 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1552054 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA] | CTD | PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1552054 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ADIPOQ mRNA | CTD | PMID:21570461 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:1552054 | 6480464 | Glucosamine results in increased expression of ADIPOQ mRNA | CTD | PMID:15694357 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of ADIPOQ mRNA | CTD | PMID:15694357 |
| 2-butoxyethanol | decreases expression | ISO | RGD:1552054 | 6480464 | n-butoxyethanol results in decreased expression of ADIPOQ mRNA | CTD | PMID:19812364 |
| 3',5'-cyclic AMP | increases abundance | ISO | RGD:1351472 | 6480464 | ADIPOQ protein results in increased abundance of Cyclic AMP | CTD | PMID:18931039 |
| 3,3',4,4',5-pentachlorobiphenyl | affects expression | ISO | RGD:1351472 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl affects the expression of ADIPOQ mRNA | CTD | PMID:21703328 |
| 3,3',4,4'-tetrachlorobiphenyl | decreases expression | ISO | RGD:1552054 | 6480464 | 3,4,3',4'-tetrachlorobiphenyl results in decreased expression of ADIPOQ mRNA | CTD | PMID:21925196 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1552054 | 6480464 | Benzo(a)pyrene inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of ADIPOQ mRNA]; more ... | CTD | PMID:19141685 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1351472 | 6480464 | [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of ADIPOQ mRNA; more ... | CTD | PMID:23086663 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1552054 | 6480464 | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; more ... | CTD | PMID:23086663 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1351472 | 6480464 | aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in decreased expression of ADIPOQ mRNA] | CTD | PMID:22645054 |
| 3-isobutyl-1-methyl-7H-xanthine | decreases expression | ISO | RGD:1351472 | 6480464 | 1-Methyl-3-isobutylxanthine results in decreased expression of ADIPOQ mRNA | CTD | PMID:22645054 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1552054 | 6480464 | bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]; more ... | CTD | PMID:22197818 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1351472 | 6480464 | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA; more ... | CTD | PMID:19186324 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1552054 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; more ... | CTD | PMID:16054899 |
| 3-isobutyl-1-methyl-7H-xanthine | increases expression | ISO | RGD:1552054 | 6480464 | 1-Methyl-3-isobutylxanthine results in increased expression of ADIPOQ mRNA | CTD | PMID:19141685 |
| 5,6,7,8-tetrahydrobiopterin | multiple interactions | EXP | | 6480464 | 5,6,7,8-tetrahydrobiopterin inhibits the reaction [Fructose results in decreased expression of ADIPOQ mRNA]; more ... | CTD | PMID:17098227 |
| 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide | increases expression | ISO | RGD:1552054 | 6480464 | AICA ribonucleotide results in increased expression of ADIPOQ protein | CTD | PMID:20980258 |
| acarbose | increases expression | EXP | | 6480464 | Acarbose results in increased expression of ADIPOQ protein | CTD | PMID:18290871 |
| acetaldehyde | multiple interactions | ISO | RGD:1351472 | 6480464 | ADIPOQ protein inhibits the reaction [Acetaldehyde results in decreased expression of BCL2 mRNA]; more ... | CTD | PMID:16814256 |
| acetaldehyde | increases expression | ISO | RGD:1552054 | 6480464 | Acetaldehyde results in increased expression of ADIPOQ mRNA; more ... | CTD | PMID:17949463 |
| acetaldehyde | multiple interactions | ISO | RGD:1552054 | 6480464 | Acetaldehyde promotes the reaction [ADIPOQ protein results in decreased expression of COL1A1 mRNA]; more ... | CTD | PMID:17949463 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:1552054 | 6480464 | Glucosamine results in increased expression of ADIPOQ mRNA | CTD | PMID:15694357 |
| aldehydo-D-glucosamine | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of ADIPOQ mRNA | CTD | PMID:15694357 |
| allopurinol | multiple interactions | EXP | | 6480464 | Allopurinol promotes the reaction [Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ mRNA]]; more ... | CTD | PMID:21912612 |
| amlodipine | increases expression | ISO | RGD:1351472 | 6480464 | Amlodipine results in increased expression of ADIPOQ | CTD | PMID:19059660 |
| amlodipine | increases expression | ISO | RGD:1351472 | 6480464 | Amlodipine results in increased expression of ADIPOQ protein | CTD | PMID:18199500 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ADIPOQ mRNA | CTD | PMID:16483693 |
| arsenic atom | increases expression | ISO | RGD:1552054 | 6480464 | Arsenic results in increased expression of ADIPOQ mRNA | CTD | PMID:19654921 |
| benzbromarone | multiple interactions | ISO | RGD:1552054 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [Benzbromarone results in increased expression of ADIPOQ mRNA] | CTD | PMID:19048458 |
| benzbromarone | increases expression | ISO | RGD:1351472 | 6480464 | Benzbromarone results in increased expression of ADIPOQ protein | CTD | PMID:21329621 PMID:19048458 |
| benzbromarone | increases expression | ISO | RGD:1351472 | 6480464 | Benzbromarone results in increased expression of ADIPOQ protein | CTD | PMID:19048458 PMID:21329621 |
| benzbromarone | increases expression | ISO | RGD:1552054 | 6480464 | Benzbromarone results in increased expression of ADIPOQ mRNA | CTD | PMID:19048458 |
| benzene | increases expression | ISO | RGD:1552054 | 6480464 | Benzene results in increased expression of ADIPOQ mRNA | CTD | PMID:15122651 PMID:15120971 |
| benzene | increases expression | ISO | RGD:1552054 | 6480464 | Benzene results in increased expression of ADIPOQ mRNA | CTD | PMID:15120971 PMID:15122651 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1552054 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of ADIPOQ mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ADIPOQ mRNA | CTD | PMID:22374506 |
| benzo[a]pyrene | increases expression | ISO | RGD:1552054 | 6480464 | Benzo(a)pyrene results in increased expression of ADIPOQ mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1552054 | 6480464 | Benzo(a)pyrene inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of ADIPOQ mRNA] | CTD | PMID:19141685 |
| berberine | multiple interactions | ISO | RGD:1552054 | 6480464 | Berberine inhibits the reaction [Clozapine results in increased expression of ADIPOQ mRNA]; more ... | CTD | PMID:20564506 |
| beta-carotene | decreases expression | ISO | RGD:1552054 | 6480464 | beta Carotene results in decreased expression of ADIPOQ mRNA | CTD | PMID:21569430 |
| beta-D-glucosamine | increases expression | ISO | RGD:1552054 | 6480464 | Glucosamine results in increased expression of ADIPOQ mRNA | CTD | PMID:15694357 |
| beta-D-glucosamine | increases expression | EXP | | 6480464 | Glucosamine results in increased expression of ADIPOQ mRNA | CTD | PMID:15694357 |
| bezafibrate | increases expression | ISO | RGD:1552054 | 6480464 | Bezafibrate results in increased expression of ADIPOQ protein | CTD | PMID:17190905 more ... |
| bezafibrate | increases expression | ISO | RGD:1552054 | 6480464 | Bezafibrate results in increased expression of ADIPOQ protein | CTD | PMID:16574099 more ... |
| bezafibrate | increases secretion | ISO | RGD:1552054 | 6480464 | Bezafibrate results in increased secretion of ADIPOQ protein | CTD | PMID:17190905 |
| bezafibrate | increases expression | ISO | RGD:1552054 | 6480464 | Bezafibrate results in increased expression of ADIPOQ protein | CTD | PMID:18513333 more ... |
| bezafibrate | increases expression | ISO | RGD:1552054 | 6480464 | Bezafibrate results in increased expression of ADIPOQ mRNA | CTD | PMID:21324916 |
| bezafibrate | increases expression | ISO | RGD:1351472 | 6480464 | Bezafibrate results in increased expression of ADIPOQ protein | CTD | PMID:21411093 |
| bezafibrate | increases expression | ISO | RGD:1552054 | 6480464 | Bezafibrate results in increased expression of ADIPOQ protein | CTD | PMID:21549692 more ... |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:1552054 | 6480464 | Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA] | CTD | PMID:22197818 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1552054 | 6480464 | Diethylhexyl Phthalate results in decreased expression of ADIPOQ mRNA | CTD | PMID:22588786 |
| bisphenol A | multiple interactions | ISO | RGD:1552054 | 6480464 | bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA] | CTD | PMID:22197818 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ADIPOQ mRNA | CTD | PMID:17010207 |
| bisphenol A | decreases expression | ISO | RGD:1552054 | 6480464 | bisphenol A results in decreased expression of ADIPOQ mRNA | CTD | PMID:18417718 |
| bisphenol A | decreases secretion | ISO | RGD:1351472 | 6480464 | bisphenol A results in decreased secretion of ADIPOQ protein | CTD | PMID:19079714 |
| cadmium dichloride | decreases expression | ISO | RGD:1552054 | 6480464 | Cadmium Chloride results in decreased expression of ADIPOQ mRNA | CTD | PMID:19666079 |
| calcitriol | multiple interactions | ISO | RGD:1351472 | 6480464 | [Calcitriol co-treated with Cortisone] results in decreased expression of ADIPOQ mRNA | CTD | PMID:19918113 |
| candesartan | multiple interactions | ISO | RGD:1351472 | 6480464 | [candesartan co-treated with Fenofibrate] results in increased expression of ADIPOQ protein | CTD | PMID:16443859 |
| candesartan | increases expression | ISO | RGD:1351472 | 6480464 | candesartan results in increased expression of ADIPOQ | CTD | PMID:17483542 PMID:19059660 |
| candesartan | increases expression | ISO | RGD:1351472 | 6480464 | candesartan results in increased expression of ADIPOQ protein | CTD | PMID:16443859 |
| candesartan | increases expression | ISO | RGD:1351472 | 6480464 | candesartan results in increased expression of ADIPOQ | CTD | PMID:19059660 PMID:17483542 |
| candesartan | decreases expression | ISO | RGD:1351472 | 6480464 | candesartan results in decreased expression of ADIPOQ | CTD | PMID:17483542 |
| candesartan | multiple interactions | ISO | RGD:1351472 | 6480464 | candesartan promotes the reaction [Ramipril results in increased expression of ADIPOQ]; more ... | CTD | PMID:17483542 |
| capsaicin | increases expression | ISO | RGD:1552054 | 6480464 | Capsaicin results in increased expression of ADIPOQ mRNA | CTD | PMID:19798065 PMID:17719033 |
| capsaicin | increases expression | ISO | RGD:1552054 | 6480464 | Capsaicin results in increased expression of ADIPOQ protein | CTD | PMID:17295509 PMID:19798065 |
| capsaicin | increases expression | ISO | RGD:1552054 | 6480464 | Capsaicin results in increased expression of ADIPOQ mRNA | CTD | PMID:17719033 PMID:19798065 |
| capsaicin | increases secretion | ISO | RGD:1552054 | 6480464 | Capsaicin results in increased secretion of ADIPOQ protein | CTD | PMID:17719033 |
| capsaicin | increases expression | ISO | RGD:1552054 | 6480464 | Capsaicin results in increased expression of ADIPOQ mRNA | CTD | PMID:17719033 |
| capsaicin | increases expression | ISO | RGD:1552054 | 6480464 | Capsaicin results in increased expression of ADIPOQ protein | CTD | PMID:17295509 |
| capsaicin | increases expression | ISO | RGD:1552054 | 6480464 | Capsaicin results in increased expression of ADIPOQ protein | CTD | PMID:19798065 PMID:17295509 |
| carbon monoxide | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein]; more ... | CTD | PMID:19356108 |
| carbon monoxide | increases expression | EXP | | 6480464 | [Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased expression of PECAM1 protein | CTD | PMID:19356108 |
| carvedilol | decreases expression | ISO | RGD:1351472 | 6480464 | carvedilol results in decreased expression of ADIPOQ protein | CTD | PMID:19367012 |
| cimetidine | multiple interactions | ISO | RGD:1351472 | 6480464 | Cimetidine promotes the reaction [Metformin results in decreased expression of ADIPOQ mRNA] | CTD | PMID:20956498 |
| clozapine | decreases expression | ISO | RGD:1351472 | 6480464 | Clozapine results in decreased expression of ADIPOQ protein | CTD | PMID:18162013 |
| clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of ADIPOQ protein | CTD | PMID:17933447 |
| clozapine | increases expression | ISO | RGD:1552054 | 6480464 | Clozapine results in increased expression of ADIPOQ mRNA | CTD | PMID:20564506 |
| clozapine | multiple interactions | ISO | RGD:1552054 | 6480464 | Berberine inhibits the reaction [Clozapine results in increased expression of ADIPOQ mRNA] | CTD | PMID:20564506 |
| cobalt dichloride | increases secretion | ISO | RGD:1552054 | 6480464 | cobaltous chloride results in increased secretion of ADIPOQ protein | CTD | PMID:22019852 |
| cobalt dichloride | decreases expression | ISO | RGD:1552054 | 6480464 | cobaltous chloride results in decreased expression of ADIPOQ mRNA | CTD | PMID:20594416 |
| cortisone | multiple interactions | ISO | RGD:1351472 | 6480464 | [Calcitriol co-treated with Cortisone] results in decreased expression of ADIPOQ mRNA | CTD | PMID:19918113 |
| crocetin | multiple interactions | EXP | | 6480464 | crocetin inhibits the reaction [Palmitates results in decreased expression of ADIPOQ mRNA]; more ... | CTD | PMID:17471172 |
| curcumin | increases expression | ISO | RGD:1552054 | 6480464 | Curcumin results in increased expression of ADIPOQ protein; more ... | CTD | PMID:18403477 |
| D-glucose | multiple interactions | EXP | | 6480464 | ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein] | CTD | PMID:21912612 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of ADIPOQ protein | CTD | PMID:21912612 |
| DDE | increases expression | ISO | RGD:1552054 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of ADIPOQ mRNA | CTD | PMID:21044676 |
| DDE | increases secretion | ISO | RGD:1552054 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased secretion of ADIPOQ protein | CTD | PMID:21044676 |
| dexamethasone | multiple interactions | ISO | RGD:1552054 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; more ... | CTD | PMID:16054899 |
| dexamethasone | increases expression | ISO | RGD:1351472 | 6480464 | Dexamethasone results in increased expression of ADIPOQ mRNA | CTD | PMID:19853017 |
| dexamethasone | multiple interactions | ISO | RGD:1552054 | 6480464 | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; more ... | CTD | PMID:23086663 |
| dexamethasone | multiple interactions | ISO | RGD:1351472 | 6480464 | [triflumizol co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of ADIPOQ mRNA; more ... | CTD | PMID:23086663 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of ADIPOQ mRNA | CTD | PMID:23166830 |
| dexamethasone | multiple interactions | ISO | RGD:1552054 | 6480464 | bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA]; more ... | CTD | PMID:22197818 |
| dexamethasone | multiple interactions | ISO | RGD:1351472 | 6480464 | [Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA; more ... | CTD | PMID:19186324 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of ADIPOQ mRNA | CTD | PMID:17010207 |
| dioxygen | decreases expression | ISO | RGD:1552054 | 6480464 | Oxygen deficiency results in decreased expression of ADIPOQ mRNA | CTD | PMID:20594416 |
| disodium selenite | decreases expression | ISO | RGD:1351472 | 6480464 | Sodium Selenite results in decreased expression of ADIPOQ mRNA | CTD | PMID:18175754 |
| doxorubicin | multiple interactions | ISO | RGD:1552054 | 6480464 | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of ADIPOQ mRNA | CTD | PMID:21040762 |
| ethanol | decreases expression | ISO | RGD:1552054 | 6480464 | Ethanol results in decreased expression of ADIPOQ mRNA; more ... | CTD | PMID:20007851 |
| ethanol | decreases expression | ISO | RGD:1552054 | 6480464 | Ethanol results in decreased expression of ADIPOQ mRNA | CTD | PMID:18755807 PMID:20007851 |
| ethanol | multiple interactions | ISO | RGD:1552054 | 6480464 | [Ethanol co-treated with resveratrol] results in increased expression of ADIPOQ protein; more ... | CTD | PMID:18755807 |
| ethanol | multiple interactions | EXP | | 6480464 | ADIPOQ protein inhibits the reaction [Ethanol promotes the reaction [Lipopolysaccharides results in increased expression of IFNB mRNA]]; more ... | CTD | PMID:20861358 |
| ethanol | multiple interactions | EXP | | 6480464 | ADIPOR1 protein promotes the reaction [Ethanol promotes the reaction [ADIPOQ protein results in increased expression of IL10 mRNA]]; more ... | CTD | PMID:20052772 |
| ethanol | multiple interactions | ISO | RGD:1552054 | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of ADIPOQ protein]; more ... | CTD | PMID:20007851 |
| fenofibrate | multiple interactions | ISO | RGD:1351472 | 6480464 | [candesartan co-treated with Fenofibrate] results in increased expression of ADIPOQ protein | CTD | PMID:16443859 |
| fenofibrate | increases expression | ISO | RGD:1351472 | 6480464 | Fenofibrate results in increased expression of ADIPOQ protein | CTD | PMID:16443859 |
| fructose | multiple interactions | EXP | | 6480464 | 5,6,7,8-tetrahydrobiopterin inhibits the reaction [Fructose results in decreased expression of ADIPOQ mRNA]; more ... | CTD | PMID:17098227 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of ADIPOQ protein | CTD | PMID:21122807 |
| fructose | increases secretion | EXP | | 6480464 | Fructose results in increased secretion of ADIPOQ protein | CTD | PMID:19165636 |
| fructose | decreases expression | EXP | | 6480464 | Fructose results in decreased expression of ADIPOQ mRNA; more ... | CTD | PMID:17098227 |
| glucose | multiple interactions | EXP | | 6480464 | ADIPOQ protein inhibits the reaction [Glucose results in decreased expression of ADIPOR2 protein] | CTD | PMID:21912612 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of ADIPOQ protein | CTD | PMID:21912612 |
| hydrogen peroxide | decreases secretion | ISO | RGD:1552054 | 6480464 | Hydrogen Peroxide results in decreased secretion of ADIPOQ protein | CTD | PMID:18303122 |
| hydroxytyrosol | decreases expression | ISO | RGD:1552054 | 6480464 | 3,4-dihydroxyphenylethanol results in decreased expression of ADIPOQ mRNA | CTD | PMID:21569430 |
| indinavir | decreases expression | ISO | RGD:1351472 | 6480464 | Indinavir results in decreased expression of ADIPOQ protein | CTD | PMID:17668557 |
| indinavir | decreases expression | ISO | RGD:1552054 | 6480464 | Indinavir results in decreased expression of ADIPOQ mRNA; more ... | CTD | PMID:15865214 |
| indinavir | multiple interactions | ISO | RGD:1351472 | 6480464 | diphenyleneiodonium inhibits the reaction [Indinavir results in decreased expression of ADIPOQ protein] | CTD | PMID:17668557 |
| indomethacin | multiple interactions | ISO | RGD:1351472 | 6480464 | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of ADIPOQ mRNA; more ... | CTD | PMID:23086663 |
| lamivudine | multiple interactions | ISO | RGD:1552054 | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ADIPOQ mRNA | CTD | PMID:16931933 |
| lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of ADIPOQ mRNA | CTD | PMID:11578147 |
| losartan | increases expression | ISO | RGD:1552054 | 6480464 | Losartan results in increased expression of ADIPOQ mRNA | CTD | PMID:19730415 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of AKT1 protein]; more ... | CTD | PMID:19356108 |
| melatonin | decreases expression | ISO | RGD:1351472 | 6480464 | Melatonin results in decreased expression of ADIPOQ mRNA | CTD | PMID:20738756 |
| metformin | decreases expression | ISO | RGD:1351472 | 6480464 | Metformin results in decreased expression of ADIPOQ mRNA | CTD | PMID:20956498 |
| metformin | multiple interactions | ISO | RGD:1351472 | 6480464 | Cimetidine promotes the reaction [Metformin results in decreased expression of ADIPOQ mRNA] | CTD | PMID:20956498 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Palmitates results in decreased expression of ADIPOQ protein]; more ... | CTD | PMID:17471172 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ mRNA]; more ... | CTD | PMID:21912612 |
| nevirapine | increases expression | ISO | RGD:1351472 | 6480464 | Nevirapine results in increased expression of ADIPOQ mRNA | CTD | PMID:21619898 |
| nevirapine | increases secretion | ISO | RGD:1351472 | 6480464 | Nevirapine results in increased secretion of ADIPOQ protein | CTD | PMID:21619898 |
| nicotinamide | increases secretion | ISO | RGD:1552054 | 6480464 | Niacinamide results in increased secretion of ADIPOQ protein | CTD | PMID:17452443 |
| nicotinamide | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of ADIPOQ protein] | CTD | PMID:21439372 |
| nicotinic acid | multiple interactions | ISO | RGD:1351472 | 6480464 | Niacin promotes the reaction [ADIPOQ protein binds to ADIPOQ protein] | CTD | PMID:17996241 PMID:18249215 |
| nicotinic acid | increases expression | ISO | RGD:1351472 | 6480464 | Niacin results in increased expression of ADIPOQ protein | CTD | PMID:16887123 more ... |
| nicotinic acid | increases expression | ISO | RGD:1351472 | 6480464 | Niacin results in increased expression of ADIPOQ protein | CTD | PMID:18249215 more ... |
| nicotinic acid | increases expression | ISO | RGD:1351472 | 6480464 | Niacin results in increased expression of ADIPOQ protein | CTD | PMID:16887123 more ... |
| nicotinic acid | increases expression | ISO | RGD:1351472 | 6480464 | Niacin results in increased expression of ADIPOQ protein | CTD | PMID:17996241 more ... |
| nicotinic acid | increases expression | ISO | RGD:1351472 | 6480464 | Niacin results in increased expression of ADIPOQ protein | CTD | PMID:17996241 more ... |
| nicotinic acid | increases expression | ISO | RGD:1351472 | 6480464 | Niacin results in increased expression of ADIPOQ protein | CTD | PMID:16887123 more ... |
| nicotinic acid | multiple interactions | ISO | RGD:1351472 | 6480464 | Niacin promotes the reaction [ADIPOQ protein binds to ADIPOQ protein] | CTD | PMID:18249215 PMID:17996241 |
| nicotinic acid | increases expression | EXP | | 6480464 | Niacin results in increased expression of ADIPOQ protein | CTD | PMID:19141678 |
| nicotinic acid | multiple interactions | ISO | RGD:1552054 | 6480464 | NIACR1 protein promotes the reaction [Niacin results in increased expression of ADIPOQ protein] | CTD | PMID:19141678 |
| nicotinic acid | increases expression | ISO | RGD:1552054 | 6480464 | Niacin results in increased expression of ADIPOQ protein | CTD | PMID:19141678 |
| nicotinic acid | increases expression | ISO | RGD:1552054 | 6480464 | Niacin results in increased expression of ADIPOQ mRNA | CTD | PMID:21236357 |
| nicotinic acid | increases expression | ISO | RGD:1351472 | 6480464 | Niacin results in increased expression of ADIPOQ protein | CTD | PMID:19131065 more ... |
| nicotinic acid | increases expression | ISO | RGD:1351472 | 6480464 | Niacin results in increased expression of ADIPOQ mRNA | CTD | PMID:19131065 |
| olanzapine | increases expression | ISO | RGD:1552054 | 6480464 | olanzapine results in increased expression of ADIPOQ mRNA | CTD | PMID:17651982 |
| ozone | decreases expression | ISO | RGD:1552054 | 6480464 | Ozone results in decreased expression of ADIPOQ mRNA | CTD | PMID:12763052 |
| phenobarbital | decreases expression | ISO | RGD:1552054 | 6480464 | Phenobarbital results in decreased expression of ADIPOQ mRNA | CTD | PMID:19270015 |
| pioglitazone | multiple interactions | ISO | RGD:1552054 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone results in increased expression of ADIPOQ mRNA] | CTD | PMID:19048458 |
| pioglitazone | multiple interactions | ISO | RGD:1552054 | 6480464 | pioglitazone promotes the reaction [Palmitates results in increased secretion of ADIPOQ protein] | CTD | PMID:18303122 |
| pioglitazone | increases expression | ISO | RGD:1552054 | 6480464 | pioglitazone results in increased expression of ADIPOQ protein | CTD | PMID:18513333 |
| pioglitazone | increases expression | ISO | RGD:1552054 | 6480464 | pioglitazone results in increased expression of ADIPOQ mRNA | CTD | PMID:19048458 PMID:12927809 |
| pioglitazone | multiple interactions | ISO | RGD:1552054 | 6480464 | PPARG protein affects the reaction [pioglitazone results in increased expression of ADIPOQ mRNA] | CTD | PMID:12927809 |
| pioglitazone | increases expression | ISO | RGD:1552054 | 6480464 | pioglitazone results in increased expression of ADIPOQ mRNA | CTD | PMID:12927809 PMID:19048458 |
| pirinixic acid | multiple interactions | ISO | RGD:1552054 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ADIPOQ mRNA | CTD | PMID:19710929 |
| pirinixic acid | multiple interactions | ISO | RGD:1552054 | 6480464 | [rosiglitazone co-treated with pirinixic acid] results in increased expression of ADIPOQ protein | CTD | PMID:16306350 |
| pirinixic acid | increases expression | ISO | RGD:1552054 | 6480464 | pirinixic acid results in increased expression of ADIPOQ protein; more ... | CTD | PMID:20558911 |
| progesterone | affects expression | ISO | RGD:1552054 | 6480464 | Progesterone affects the expression of ADIPOQ mRNA | CTD | PMID:17251523 |
| raloxifene | increases expression | ISO | RGD:1552054 | 6480464 | Raloxifene results in increased expression of ADIPOQ mRNA | CTD | PMID:16643890 |
| ramipril | multiple interactions | ISO | RGD:1351472 | 6480464 | candesartan promotes the reaction [Ramipril results in increased expression of ADIPOQ]; more ... | CTD | PMID:17483542 |
| ramipril | increases expression | ISO | RGD:1351472 | 6480464 | Ramipril results in increased expression of ADIPOQ | CTD | PMID:19059660 PMID:17483542 |
| ramipril | decreases expression | ISO | RGD:1351472 | 6480464 | Ramipril results in decreased expression of ADIPOQ | CTD | PMID:17483542 |
| ramipril | increases expression | ISO | RGD:1351472 | 6480464 | Ramipril results in increased expression of ADIPOQ | CTD | PMID:17483542 PMID:19059660 |
| resveratrol | increases expression | ISO | RGD:1552054 | 6480464 | resveratrol results in increased expression of ADIPOQ mRNA | CTD | PMID:22309033 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of ADIPOQ protein] | CTD | PMID:21439372 |
| resveratrol | multiple interactions | ISO | RGD:1552054 | 6480464 | [Ethanol co-treated with resveratrol] results in increased expression of ADIPOQ protein; more ... | CTD | PMID:18755807 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of ADIPOQ protein | CTD | PMID:19356108 PMID:21439372 |
| resveratrol | increases expression | ISO | RGD:1552054 | 6480464 | resveratrol results in increased expression of ADIPOQ protein | CTD | PMID:20980258 |
| resveratrol | multiple interactions | ISO | RGD:1351472 | 6480464 | resveratrol inhibits the reaction [IL1B protein results in decreased expression of ADIPOQ mRNA] | CTD | PMID:20531350 |
| resveratrol | multiple interactions | ISO | RGD:1552054 | 6480464 | GSTK1 protein affects the reaction [resveratrol promotes the reaction [ADIPOQ protein binds to ADIPOQ protein]]; more ... | CTD | PMID:20980258 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of ADIPOQ protein | CTD | PMID:19356108 |
| resveratrol | decreases secretion | ISO | RGD:1552054 | 6480464 | resveratrol results in decreased secretion of ADIPOQ protein | CTD | PMID:17452443 |
| resveratrol | multiple interactions | ISO | RGD:1552054 | 6480464 | resveratrol inhibits the reaction [TNF protein results in decreased expression of ADIPOQ mRNA]; more ... | CTD | PMID:17967414 |
| resveratrol | multiple interactions | ISO | RGD:1552054 | 6480464 | ERO1L protein inhibits the reaction [resveratrol results in decreased secretion of ADIPOQ protein] | CTD | PMID:17452443 |
| resveratrol | multiple interactions | ISO | RGD:1552054 | 6480464 | resveratrol inhibits the reaction [stearic acid results in decreased expression of ADIPOQ mRNA] | CTD | PMID:17374693 |
| resveratrol | increases expression | ISO | RGD:1552054 | 6480464 | resveratrol results in increased expression of ADIPOQ protein | CTD | PMID:20980258 PMID:22309033 |
| risperidone | multiple interactions | ISO | RGD:1552054 | 6480464 | Berberine inhibits the reaction [Risperidone results in increased expression of ADIPOQ mRNA] | CTD | PMID:20564506 |
| risperidone | increases expression | ISO | RGD:1552054 | 6480464 | Risperidone results in increased expression of ADIPOQ mRNA | CTD | PMID:20564506 |
| rosiglitazone | affects response to substance | ISO | RGD:1552054 | 6480464 | ADIPOQ protein affects the susceptibility to rosiglitazone | CTD | PMID:19940263 |
| rosiglitazone | increases expression | ISO | RGD:1552054 | 6480464 | rosiglitazone results in increased expression of ADIPOQ mRNA | CTD | PMID:19940263 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:1351472 | 6480464 | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with Indomethacin co-treated with INS protein] results in increased expression of ADIPOQ mRNA | CTD | PMID:23086663 |
| rosiglitazone | multiple interactions | ISO | RGD:1552054 | 6480464 | [rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA | CTD | PMID:23086663 |
| rosiglitazone | increases expression | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased expression of ADIPOQ mRNA | CTD | PMID:15277403 more ... |
| rosiglitazone | increases expression | ISO | RGD:1552054 | 6480464 | rosiglitazone results in increased expression of ADIPOQ mRNA | CTD | PMID:19940263 PMID:22763116 |
| rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of ADIPOQ mRNA | CTD | PMID:21515302 |
| rosiglitazone | increases expression | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:15991021 more ... |
| rosiglitazone | increases expression | ISO | RGD:1552054 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:16306350 more ... |
| rosiglitazone | affects response to substance | ISO | RGD:1351472 | 6480464 | ADIPOQ gene SNP affects the susceptibility to rosiglitazone | CTD | PMID:15855579 PMID:18036314 |
| rosiglitazone | increases secretion | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased secretion of ADIPOQ protein | CTD | PMID:20814411 more ... |
| rosiglitazone | increases expression | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:18541328 more ... |
| rosiglitazone | increases expression | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased expression of ADIPOQ mRNA | CTD | PMID:15277403 PMID:16799780 |
| rosiglitazone | increases expression | ISO | RGD:1552054 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:17932317 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of ADIPOQ mRNA | CTD | PMID:17261469 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:17261469 more ... |
| rosiglitazone | increases expression | ISO | RGD:1552054 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:19940263 more ... |
| rosiglitazone | increases expression | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:16644639 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:21373642 more ... |
| rosiglitazone | increases expression | ISO | RGD:1552054 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:21392566 more ... |
| rosiglitazone | increases secretion | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased secretion of ADIPOQ protein | CTD | PMID:20814411 more ... |
| rosiglitazone | increases expression | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:18394743 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:21373642 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of ADIPOQ mRNA | CTD | PMID:19531641 more ... |
| rosiglitazone | increases expression | ISO | RGD:1552054 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:19940263 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:1552054 | 6480464 | ADIPOQ affects the reaction [rosiglitazone results in decreased expression of SERPINE1 protein] | CTD | PMID:17932317 |
| rosiglitazone | increases secretion | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased secretion of ADIPOQ protein | CTD | PMID:15277403 more ... |
| rosiglitazone | increases expression | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:18394743 more ... |
| rosiglitazone | increases expression | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased expression of ADIPOQ mRNA | CTD | PMID:16799780 PMID:15277403 |
| rosiglitazone | affects response to substance | ISO | RGD:1351472 | 6480464 | ADIPOQ gene SNP affects the susceptibility to rosiglitazone | CTD | PMID:18036314 PMID:15855579 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone results in increased expression of and results in increased secretion of ADIPOQ protein | CTD | PMID:19531641 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein] | CTD | PMID:20965162 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of ADIPOQ mRNA | CTD | PMID:17261469 more ... |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:17261469 more ... |
| rosiglitazone | increases expression | ISO | RGD:1552054 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:19940263 more ... |
| rosiglitazone | decreases expression | ISO | RGD:1552054 | 6480464 | rosiglitazone results in decreased expression of ADIPOQ protein | CTD | PMID:20007851 |
| rosiglitazone | multiple interactions | ISO | RGD:1552054 | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of ADIPOQ mRNA]; more ... | CTD | PMID:20007851 |
| rosiglitazone | increases secretion | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased secretion of ADIPOQ protein | CTD | PMID:20814411 |
| rosiglitazone | increases expression | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:18394743 more ... |
| rosiglitazone | multiple interactions | ISO | RGD:1351472 | 6480464 | rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA] | CTD | PMID:19186324 |
| rosiglitazone | multiple interactions | ISO | RGD:1351472 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of ADIPOQ protein]; more ... | CTD | PMID:20506517 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of ADIPOQ mRNA; more ... | CTD | PMID:17261469 |
| rosiglitazone | increases expression | ISO | RGD:1552054 | 6480464 | rosiglitazone results in increased expression of ADIPOQ mRNA | CTD | PMID:19940263 |
| rosiglitazone | increases expression | ISO | RGD:1552054 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:19940263 PMID:16306350 |
| rosiglitazone | multiple interactions | ISO | RGD:1552054 | 6480464 | rosiglitazone inhibits the reaction [Nelfinavir results in decreased secretion of ADIPOQ protein]; more ... | CTD | PMID:15865214 |
| rosiglitazone | multiple interactions | ISO | RGD:1552054 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ADIPOQ mRNA; more ... | CTD | PMID:16054899 |
| rosiglitazone | multiple interactions | ISO | RGD:1552054 | 6480464 | [rosiglitazone co-treated with pirinixic acid] results in increased expression of ADIPOQ protein | CTD | PMID:16306350 |
| rosiglitazone | increases expression | ISO | RGD:1351472 | 6480464 | rosiglitazone results in increased expression of ADIPOQ protein | CTD | PMID:18541328 PMID:16644639 |
| saquinavir | decreases expression | ISO | RGD:1552054 | 6480464 | Saquinavir results in decreased expression of ADIPOQ mRNA; more ... | CTD | PMID:15865214 |
| saquinavir | multiple interactions | ISO | RGD:1552054 | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ADIPOQ mRNA | CTD | PMID:16931933 |
| saquinavir | multiple interactions | ISO | RGD:1552054 | 6480464 | rosiglitazone inhibits the reaction [Saquinavir results in decreased secretion of ADIPOQ protein] | CTD | PMID:15865214 |
| sildenafil | increases expression | ISO | RGD:1552054 | 6480464 | sildenafil results in increased expression of ADIPOQ mRNA | CTD | PMID:20471953 |
| simvastatin | multiple interactions | ISO | RGD:1552054 | 6480464 | Simvastatin promotes the reaction [Lipopolysaccharides results in increased expression of ADIPOQ mRNA]; more ... | CTD | PMID:17641834 |
| stavudine | decreases expression | ISO | RGD:1552054 | 6480464 | Stavudine results in decreased expression of ADIPOQ mRNA | CTD | PMID:15865214 |
| stavudine | decreases expression | ISO | RGD:1552054 | 6480464 | Stavudine results in decreased expression of ADIPOQ protein | CTD | PMID:15865214 PMID:17503663 |
| stavudine | decreases expression | ISO | RGD:1552054 | 6480464 | Stavudine results in decreased expression of ADIPOQ protein | CTD | PMID:17503663 PMID:15865214 |
| stavudine | decreases expression | ISO | RGD:1351472 | 6480464 | Stavudine results in decreased expression of ADIPOQ protein | CTD | PMID:17668557 |
| stearic acid | decreases expression | ISO | RGD:1552054 | 6480464 | stearic acid results in decreased expression of ADIPOQ mRNA | CTD | PMID:17374693 |
| stearic acid | multiple interactions | ISO | RGD:1552054 | 6480464 | resveratrol inhibits the reaction [stearic acid results in decreased expression of ADIPOQ mRNA] | CTD | PMID:17374693 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of ADIPOQ protein | CTD | PMID:17270171 |
| streptozocin | multiple interactions | EXP | | 6480464 | [Streptozocin co-treated with Niacinamide] results in decreased expression of ADIPOQ protein; more ... | CTD | PMID:21439372 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of ADIPOQ protein | CTD | PMID:17270171 PMID:21912612 |
| streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of ADIPOQ mRNA | CTD | PMID:21912612 |
| streptozocin | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Streptozocin results in decreased expression of ADIPOQ protein]; more ... | CTD | PMID:21912612 |
| telmisartan | increases expression | ISO | RGD:1552054 | 6480464 | telmisartan results in increased expression of ADIPOQ mRNA | CTD | PMID:19730415 |
| telmisartan | increases expression | ISO | RGD:1351472 | 6480464 | telmisartan results in increased expression of ADIPOQ protein | CTD | PMID:20555330 |
| testosterone | decreases expression | ISO | RGD:1351472 | 6480464 | Testosterone results in decreased expression of ADIPOQ | CTD | PMID:16793964 |
| testosterone | multiple interactions | EXP | | 6480464 | ADIPOQ protein inhibits the reaction [LHB protein results in increased chemical synthesis of Testosterone] | CTD | PMID:22155228 |
| testosterone | decreases chemical synthesis | EXP | | 6480464 | ADIPOQ protein results in decreased chemical synthesis of Testosterone | CTD | PMID:22155228 |
| tetrachloromethane | multiple interactions | ISO | RGD:1552054 | 6480464 | ADIPOQ protein affects the reaction [Carbon Tetrachloride results in increased expression of CTGF mRNA]; more ... | CTD | PMID:14724832 |
| tetrachloromethane | decreases expression | ISO | RGD:1552054 | 6480464 | Carbon Tetrachloride results in decreased expression of ADIPOQ protein | CTD | PMID:14724832 |
| thapsigargin | multiple interactions | ISO | RGD:1552054 | 6480464 | Thapsigargin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of ADIPOQ mRNA] | CTD | PMID:19141685 |
| topiramate | increases expression | ISO | RGD:1552054 | 6480464 | topiramate results in increased expression of ADIPOQ mRNA | CTD | PMID:12927809 |
| topiramate | increases secretion | ISO | RGD:1552054 | 6480464 | topiramate results in increased secretion of ADIPOQ protein | CTD | PMID:12927809 |
| trans-resveratrol | increases expression | ISO | RGD:1552054 | 6480464 | resveratrol results in increased expression of ADIPOQ protein | CTD | PMID:20980258 PMID:22309033 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of ADIPOQ protein] | CTD | PMID:21439372 |
| trans-resveratrol | multiple interactions | ISO | RGD:1552054 | 6480464 | [Ethanol co-treated with resveratrol] results in increased expression of ADIPOQ protein; more ... | CTD | PMID:18755807 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of ADIPOQ protein | CTD | PMID:19356108 PMID:21439372 |
| trans-resveratrol | increases expression | ISO | RGD:1552054 | 6480464 | resveratrol results in increased expression of ADIPOQ protein | CTD | PMID:20980258 |
| trans-resveratrol | multiple interactions | ISO | RGD:1351472 | 6480464 | resveratrol inhibits the reaction [IL1B protein results in decreased expression of ADIPOQ mRNA] | CTD | PMID:20531350 |
| trans-resveratrol | multiple interactions | ISO | RGD:1552054 | 6480464 | GSTK1 protein affects the reaction [resveratrol promotes the reaction [ADIPOQ protein binds to ADIPOQ protein]]; more ... | CTD | PMID:20980258 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of ADIPOQ protein | CTD | PMID:19356108 |
| trans-resveratrol | increases expression | ISO | RGD:1552054 | 6480464 | resveratrol results in increased expression of ADIPOQ mRNA | CTD | PMID:22309033 |
| trans-resveratrol | multiple interactions | ISO | RGD:1552054 | 6480464 | resveratrol inhibits the reaction [stearic acid results in decreased expression of ADIPOQ mRNA] | CTD | PMID:17374693 |
| trans-resveratrol | multiple interactions | ISO | RGD:1552054 | 6480464 | ERO1L protein inhibits the reaction [resveratrol results in decreased secretion of ADIPOQ protein] | CTD | PMID:17452443 |
| trans-resveratrol | multiple interactions | ISO | RGD:1552054 | 6480464 | resveratrol inhibits the reaction [TNF protein results in decreased expression of ADIPOQ mRNA]; more ... | CTD | PMID:17967414 |
| trans-resveratrol | decreases secretion | ISO | RGD:1552054 | 6480464 | resveratrol results in decreased secretion of ADIPOQ protein | CTD | PMID:17452443 |
| tributylstannane | multiple interactions | ISO | RGD:1552054 | 6480464 | tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADIPOQ mRNA] | CTD | PMID:22197818 |
| triclosan | decreases expression | ISO | RGD:1351472 | 6480464 | Triclosan results in decreased expression of ADIPOQ mRNA | CTD | PMID:22726953 |
| troglitazone | increases expression | ISO | RGD:1351472 | 6480464 | troglitazone results in increased expression of ADIPOQ protein | CTD | PMID:16076985 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of ADIPOQ mRNA | CTD | PMID:21515302 |
| troglitazone | decreases expression | ISO | RGD:1552054 | 6480464 | troglitazone results in decreased expression of ADIPOQ mRNA | CTD | PMID:12732648 |
| troglitazone | increases secretion | ISO | RGD:1552054 | 6480464 | troglitazone results in increased secretion of ADIPOQ protein | CTD | PMID:17452443 |
| tunicamycin | multiple interactions | ISO | RGD:1552054 | 6480464 | Tunicamycin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of ADIPOQ mRNA] | CTD | PMID:19141685 |
| tunicamycin | increases expression | ISO | RGD:1552054 | 6480464 | Tunicamycin results in increased expression of ADIPOQ mRNA | CTD | PMID:17127020 |
| valproic acid | increases expression | ISO | RGD:1351472 | 6480464 | Valproic Acid results in increased expression of ADIPOQ protein | CTD | PMID:19085528 |
| vanadium atom | multiple interactions | ISO | RGD:1552054 | 6480464 | NL-71-101 inhibits the reaction [Vanadium results in increased expression of ADIPOQ protein]; more ... | CTD | PMID:16524741 |
| vanadium(0) | multiple interactions | ISO | RGD:1552054 | 6480464 | NL-71-101 inhibits the reaction [Vanadium results in increased expression of ADIPOQ protein]; more ... | CTD | PMID:16524741 |
| vanadyl sulfate | multiple interactions | ISO | RGD:1552054 | 6480464 | vanadyl sulfate results in increased expression of and results in increased secretion of ADIPOQ protein; more ... | CTD | PMID:16524741 |
| zidovudine | decreases expression | ISO | RGD:1552054 | 6480464 | Zidovudine results in decreased expression of ADIPOQ protein | CTD | PMID:17503663 PMID:15865214 |
| zidovudine | decreases expression | ISO | RGD:1552054 | 6480464 | Zidovudine results in decreased expression of ADIPOQ protein | CTD | PMID:15865214 PMID:17503663 |
| zidovudine | decreases expression | ISO | RGD:1351472 | 6480464 | Zidovudine results in decreased expression of ADIPOQ protein | CTD | PMID:17668557 |
| zidovudine | decreases expression | ISO | RGD:1552054 | 6480464 | Zidovudine results in decreased expression of ADIPOQ mRNA | CTD | PMID:15865214 |
| zidovudine | multiple interactions | ISO | RGD:1552054 | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in decreased expression of ADIPOQ mRNA | CTD | PMID:16931933 |
| zinc protoporphyrin | multiple interactions | ISO | RGD:1552054 | 6480464 | zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB mRNA]]; more ... | CTD | PMID:20861358 |
| zinc protoporphyrin | multiple interactions | EXP | | 6480464 | zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]] | CTD | PMID:20052772 |